Adicet Bio Management
Management criteria checks 2/4
Adicet Bio's CEO is Chen Schor, appointed in Sep 2020, has a tenure of 3.67 years. total yearly compensation is $5.97M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth $201.00K. The average tenure of the management team and the board of directors is 3.6 years and 3.2 years respectively.
Key information
Chen Schor
Chief executive officer
US$6.0m
Total compensation
CEO salary percentage | 10.1% |
CEO tenure | 3.7yrs |
CEO ownership | 0.2% |
Management average tenure | 3.6yrs |
Board average tenure | 3.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$140m |
Dec 31 2023 | n/a | n/a | -US$143m |
Sep 30 2023 | n/a | n/a | -US$143m |
Jun 30 2023 | n/a | n/a | -US$115m |
Mar 31 2023 | n/a | n/a | -US$105m |
Dec 31 2022 | US$4m | US$562k | -US$70m |
Sep 30 2022 | n/a | n/a | -US$56m |
Jun 30 2022 | n/a | n/a | -US$48m |
Mar 31 2022 | n/a | n/a | -US$36m |
Dec 31 2021 | US$10m | US$536k | -US$62m |
Sep 30 2021 | n/a | n/a | -US$55m |
Jun 30 2021 | n/a | n/a | -US$56m |
Mar 31 2021 | n/a | n/a | -US$54m |
Dec 31 2020 | US$11m | US$499k | -US$37m |
Compensation vs Market: Chen's total compensation ($USD5.97M) is above average for companies of similar size in the UK market ($USD352.90K).
Compensation vs Earnings: Chen's compensation has increased whilst the company is unprofitable.
CEO
Chen Schor (51 yo)
3.7yrs
Tenure
US$5,973,807
Compensation
Mr. Chen Schor, MBA, BA, CPA, has been the Chief Executive Officer, President & Director at Adicet Bio, Inc since September 15, 2020. He was a Co-Founder of resTORbio, Inc. and served as its President and...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 3.7yrs | US$5.97m | 0.16% $ 201.0k | |
Founder & Independent Director | no data | US$240.29k | 1.04% $ 1.3m | |
Chief Financial Officer | 3.7yrs | US$2.13m | 0.068% $ 83.6k | |
Chief Technology Officer | 3.6yrs | US$2.09m | 0.043% $ 52.5k | |
Senior VP & Chief Scientific Officer | 3.1yrs | US$2.48m | 0.031% $ 37.9k | |
Chief Human Resource Officer | 2.3yrs | no data | no data | |
Chief Medical Officer & Senior VP | 3.7yrs | US$1.99m | 0.092% $ 112.5k | |
Senior VP & Chief Regulatory Officer | 1.5yrs | no data | no data |
3.6yrs
Average Tenure
58yo
Average Age
Experienced Management: 0HX7's management team is considered experienced (3.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 3.7yrs | US$5.97m | 0.16% $ 201.0k | |
Founder & Independent Director | 3.7yrs | US$240.29k | 1.04% $ 1.3m | |
Independent Chairman | 3.7yrs | US$275.29k | no data | |
Independent Director | 3.7yrs | US$254.29k | 0.0061% $ 7.4k | |
Independent Director | 3.2yrs | US$255.29k | 0% $ 0 | |
Independent Director | 3.7yrs | US$240.29k | 0% $ 0 | |
Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
Member of Scientific Advisory Board | 3.3yrs | US$2.90m | no data | |
Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
Member of Scientific Advisory Board | 2.8yrs | no data | no data |
3.2yrs
Average Tenure
66yo
Average Age
Experienced Board: 0HX7's board of directors are considered experienced (3.2 years average tenure).